Starting July 1, Medicare beneficiaries who qualify can get weight-loss drugs for $50 a month. They should consider the side ...

More employers plan to drop coverage for weight loss drugs ...

Medicare's upcoming weight-loss drug program could create major bottlenecks for doctors as millions of seniors seek access to ...

CVS Health will reinstate coverage of Eli Lilly's weight-loss injectable Zepbound and begin coverage of the anti-obesity pill Foundayo.

A new Medicare program covers GLP-1 medications like Ozempic for weight loss purposes. The program begins July 1, 2026 and ...

RoenRx, a telehealth platform providing medically supervised weight-loss care, today released updated 2026 pricing ...

A report from STAT News said Eli Lilly and the FDA gave a 79-year-old man exclusive access to the drug after a request for it ...

Syracuse, NY -- A new Medicare pilot program will launch July 1 that will offer affordable weight-loss drugs to millions of ...

Tirzepatide is the active ingredient in an injectable medication (Zepbound) approved by the U.S. Food and Drug Administration ...

Dietitians break down how diet and exercise each influence weight loss—and why the answer isn’t as simple as picking one.

A recent study found that "yo-yo dieters" may lose weight with intermittent fasting. The study compared intermittent fasting ...

"This application was not for the President," White House spokesman Kush Desai wrote on X about viral rumors regarding ...